Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan

被引:12
作者
Dai, CY
Yu, ML
Chuang, WL
Sung, MH
Lin, ZY
Chen, SC
Hsieh, MY
Wang, LY
Tsai, JF
Chang, WY
机构
[1] Kaohsiung Med Univ, Coll Med, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[2] Chann Ann Clin, Hemodialysis Unit, Kaohsiung, Taiwan
关键词
TT virus; GBV-C/HGV; HCV; hemodialysis;
D O I
10.1159/000049035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: A novel DNA virus which was designated TT virus (TTV) in 1997 was considered a possible hepatitis-related virus, like hepatitis C (HCV), hepatitis B (HBV) and GB virus C/hepatitis G viruses (GBV-C/HGV). In the present study, the molecular epidemiology and clinical significance of TTV, GBV-C/HGV and HCV infection in hemodialysis patients from Taiwan are investigated. Methods: Sera of 85 patients on maintenance hemodialysis were tested for alanine aminotransferase (ALT), hepatitis B surface antigen (HBsAg), second-generation HCV antibody (anti-HCV), anti-envelope protein 2 antibody (anti-E2) and RNA of GBV-C/HGV, HCV RNA and TTV DNA. Sera of patients with positive TTV DNA, GBV-C/HGV RNA or HCV RNA were tested for viruses 2 years later. Results: Seven (8.2%) 29 (34.1%), 21 (24.7%), 12 (14.1%) and 9 (10.6%) hemodialysis patients were positive for HBsAg, Anti-HCV, HCV RNA, GBV-C/HGV RNA and anti-E2, respectively. TTV DNA was positive in 46 (54.1%) patients. Neither clinical nor virological factors were associated with TTV viremia. The ALT level was significantly elevated in HCV RNA-positive individuals than -negative ones (34.5 vs. 12.5%, p < 0.05). TTV DNA, GBV-C/HGV RNA and HCV RNA remained detectable in sera of 31 (86.1%),6 (50 %) and 21 (100%) patients collected 2 years after first diagnosis of viremia. Conclusion: Among Taiwanese hemodialysis patients, TTV infection is highly prevalent. No clinical or virological factor was observed to be significantly associated with TTV infection. The ALT abnormality was mainly attributable to HCV but not TTV infection in Taiwanese hemodialysis patients. Copyright (C) 2002 S. KargerAG, Basel.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 61 条
[1]   The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease [J].
Alter, HJ ;
Nakatsuji, Y ;
Melpolder, J ;
Wages, J ;
Wesley, R ;
Shih, JWK ;
Kim, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (11) :747-754
[2]   Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection [J].
Alter, MJ ;
Gallagher, M ;
Morris, TT ;
Moyer, LA ;
Meeks, EL ;
Krawczynski, K ;
Kim, JP ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (11) :741-746
[3]  
CHAN YJ, 2000, CHUNG HUA MIN KUO WE, V33, P14
[4]   TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis [J].
Charlton, M ;
Adjei, P ;
Poterucha, J ;
Zein, N ;
Moore, B ;
Therneau, T ;
Krom, R ;
Wiesner, R .
HEPATOLOGY, 1998, 28 (03) :839-842
[5]   Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre [J].
Desassis, JF ;
Laperche, S ;
Girault, A ;
Kolko, A ;
Bouchardeau, F ;
Zins, B ;
Poignet, JL ;
Couroucé, AM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) :2692-2697
[6]   Parenteral and sexual transmission of GB virus C and hepatitis C virus among human immunodeficiency virus-positive patients [J].
Fiordalisi, G ;
Bettinardi, A ;
Zanella, I ;
Stellini, R ;
Paraninfo, G ;
Cadeo, G ;
Primi, D .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :1025-1026
[7]  
Fujiwara T, 1998, LANCET, V352, P1310, DOI 10.1016/S0140-6736(05)70520-1
[8]   TT virus infection in French hemodialysis patients: Study of prevalence and risk factors [J].
Gallian, P ;
Berland, Y ;
Olmer, M ;
Raccah, D ;
de Micco, P ;
Biagini, P ;
Simon, S ;
Bouchouareb, D ;
Mourey, C ;
Roubicek, C ;
Touinssi, M ;
Cantaloube, JF ;
Dussol, B ;
de Lamballerie, X .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (08) :2538-2542
[9]   Transfusion-transmitted virus infection in China: Prevalence in blood donors and in patients with liver diseases [J].
He, C ;
Nomura, F ;
Yukimasa, N ;
Itoga, S ;
Yamada-Osaki, M ;
Sumazaki, R ;
Nakai, T .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (09) :899-903
[10]  
Höhne M, 1998, J GEN VIROL, V79, P2761